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D-a-aminobutyrate by active-site mutants of AspefgMus nidulans 
isopenicillin N synthase 
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John D Sutherland 
Background: Penicillins and cephalosporins constitute a major class of 
clinically useful antibiotics. A key step in their biosynthesis involves the oxidative 
cyclisation of 6-(L-a-aminoadipoyl)-L-cysteinyl-o-valine to isopenicillin N by 
isopenicillin N synthase (IPNS). This chemically remarkable transformation has 
been extensively studied using substrate analogues. The conversion of an 
analogue in which the valine is replaced by a-aminobutyrate results in three 
products, two epimeric penams and a cepham. The ratio of ttiese products in 
reactions catalysed by four different IPNS isozymes has been used previously 
to probe the thermicity of the chemical mechanism. But how IPNS restricts the 
products from the natural substrate to a single penam (isopenicillin N) has 
remained unknown. 
Results: A key active-site residue, Leu223, identified according to a model of 
enzyme-substrate binding, has been altered to sterically less demanding 
residues. As the steric constraints on the upper part of the active site are 
reduced, the ratio of the P-methyl penam to the cepham increases when the 
a-aminobutyrate-containing substrate analogue is used. These results suggest 
a mechanism for processing of the natural substrate in which IPNS uses steric 
control to restrict the conformational freedom of an intermediate such that the 
only product is the penam. 
Conclusions: Using steric pressure to control conformation, and hence to 
disfavour reactions leading to alternate products, is probably the result of 
evolutionary selection for a biologically active product at the expense of 
biologically inactive byproducts. It is likely that this sort of enzymatic catalysis is 
used in situations where substrate conversion is highly exothermic and a variety 
of products are possible. 
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Introduction 
A key step in the biosynthesis of penicillins and 
cephalosporins, which together constitute a major class of 
antibiotics, is the conversion of &(t,-a-aminoadipoyl)- 
L-cysteinyl-D-valine (ACV, 1) to isopenicillin N (IPN, 2; 
see Figure 1) [1,2]. This chemically unusual four-electron 
oxidative transformation is mediated by isopenicillin N 
synthase (IPNS), an enzyme that has been the subject of 
intensive study. When the X-ray crystal structure of 
Aspeq$hs nidulans IPNS complexed with manganese II 
ions was solved [3] it did not indicate the mode of sub- 
strate binding, so a model was required [4]. The structure 
revealed four enzyme metal ligands, HisZ14, Asp216, 
His270 and Gln330. The finding that Gln330, the penulti- 
mate residue of the protein, was a metal ligand through its 
sidechain was unexpected. Other members of the 
sequence-homologous enzyme family have the two histi- 
dine and the aspartate ligands but lack the glutamine 
ligand. This observation has to be reconciled with the fact 
that although the other members of the family (for 
example deacetoxycephalosporin C synthase [S]) bind 
a-ketoglutarate as an obligate cosubstrate, IPNS does not. 
Indeed, IPNS must not bind a-ketoglutarate, as IPNS uti- 
lizes the full oxidising capacity of dioxygen to convert its 
substrate ACV 1 to isopenicillin N 2. This result sug- 
gested that IPNS might be using Gln330 as a ‘dummy’ 
ligand to prevent a-ketoglutarate from binding [4]. If 
this is the case, then the dummy ligand must, in some 
way, be displaced by the ACV 1 substrate but not by 01- 
ketoglutarate. Comparison of the a-aminoadipoyl 
sidechain of ACV 1 with the carboxy-terminal Gln330- 
Thr331 tail of IPNS revealed a compelling similarity, 
which immediately suggested that the selective displace- 
ment of the ‘dummy’ ligand by ACV 1 and not by 
a-ketoglutarate could occur by structural-functional simi- 
larity. In particular, the residues used in binding of the 
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Fiaure 1 
The reaction catalysed by isopenicillin N 
synthase (IPNS). (a) During the oxidative 
cyclisation of &(L-a-aminoadipoyl)-L- 
cysteinyl-o-valine (ACV, 1) to isopenicillin N 
(IPN, 2), one molecule of dioxygen is 
reduced to two molecules of water. 
(b) A model for substrate binding (for further 
discussion see the Introduction section). The 
first crystal structure of IPNS complexed with 
manganese II atoms revealed four enzyme 
metal ligands, His21 4, Asp21 6, His270 and 
Gln330, but did not indicate the mode of 
substrate binding. Because other enzymes in 
a sequence-homologous family bind 
a-ketoglutarate as an obligate cosubstrate 
and lack the Gln330 metal ligand it was 
postulated that the Gln330-Thr331 carboxyl 
terminus of IPNS interacts with the substrate 
binding site, preventing the binding of 
a-ketoglutarate in this case. The natural 
substrate, ACV 1, is structurally homologous 
to the Gln330-Thr331 tail, allowing the 
substrate to displace the tail [4]. IPNS is 
shown interacting with its carboxy-terminal 
tail on the left and ACV 1 on the right (both 
are shown in red, with the portion of the 
tail/substrate that is essential for interaction 
(a) 
:b) 
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with Fe indicated by a pink cloud). Note that carboxy-terminal tail) and the two water 
Fe interacts non-covalently with the four molecules; the geometry of the interactions 
metal ligands (including Gln330 of the IPNS is shown. 
carboxy-terminal Gln330-Thr331 tail to the protein (prin- 
cipally Arg87 through a salt-bridge to the carboxylate of 
Thr331 [5]) should also be involved in the binding of the 
a-aminoadipoyl sidechain of ACV 1. With this site of 
attachment of the substrate and the a-aminoadipoyl 
sidechain in an extended conformation [l], the sulphur 
atom of the cysteinyl residue of ACV 1 is in an ideal loca- 
tion to ligate the metal. We originally proposed that the 
sulphur coordinated tran~ to AspZ16; the modified coordi- 
nation shown in Figure 1 derives from subsequent crystal- 
lographic data (see below). The predicted binding model 
[4] then placed the valinyl carboxylate of the substrate 
close to ArgZ79 and Ser281, two residues completely con- 
served in the homology family mentioned earlier. We pro- 
posed that the conservation of these two residues reflects 
the fact that they are used in the binding of a-ketoglu- 
tarate in those members of the homology family that use 
this a-ketoacid as a substrate. In IPNS, a-ketoglutarate 
binding is prevented by the ‘dummy’ ligand, so the pres- 
ence of ArgZ79 and Ser281 is consistent with our proposal 
that they function to bind the valinyl carboxylate of ACV 
1. The binding model [4] indicated that the isopropyl 
group of ACV 1 would be in close proximity to the metal 
ion and in contact with a number of hydrophobic residues 
notably Leu223, Pro283, Leu231 and Va1272 (see below). 
The complete conservation of Leu231 in the homology 
family suggests that this residue is involved in a-ketoglu- 
tarate binding in other members of the family. The lack of 
general acidic and basic residues in this pocket forced us 
to propose a mechanism in which substrate deprotonation 
was mediated by an iron-ligated species. This binding 
model has recently been confirmed by X-ray crystallo- 
graphic analysis, the only minor difference being that the 
iron-coordination site is occupied by sulphur [6]. The 
recent substrate-bound crystal structure shows that the 
substrate valinyl-C-H bond points away from the iron 
centre [6]. At some stage of the reaction a rotation of the 
valinyl-C2-C3 bond must take place to orient the C-H 
bond towards the metal. Given this fact, and the require- 
ment for the enzyme to stabilise multiple intermediates 
and transition states, it is apparent that substantial flexibil- 
ity must be available to the enzyme-substrate complex as 
the reaction takes place. For this reason it is inappropriate 
to extrapolate the relative ground-state dispositions of 
substrate and enzyme to the intermediate states and tran- 
sition states considered in this paper. This caveat clearly 
applies to all mechanistic suggestions deriving from 
ground-state crystal structures. 
The chemical mechanism of IPNS has been probed 
extensively using substrate analogues, and the information 
gained from these studies, in addition to crystallographic 
data and comparisons to related enzymes, suggest a 
detailed mechanism for IPNS (see Figure 2). A key 
feature of the IPNS mechanism is the oxidative addition 
of a ferry1 oxene (10, Figure 2) to the valinyl tertiary C-H 
bond to give a metallocycle 11 from which reductive elim- 
ination generates the product 2. 
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Figure 2 
The mechanism of penicillin formation. 
Binding of the thiolate of the substrate ACV 1 
increases electron availability at the ferrous 
iron, allowing binding of dioxygen. Electron 
transfer from sulphur to oxygen via the iron 
generates a peroxy species 3, in which the 
non-ligating peroxy oxygen (red) is ideally 
positioned to function as an intramolecular 
general base for the abstraction of the 
cysteinyl-3-pro-S hydrogen (blue), giving a 
bound thioaldehyde (4). lntracomplex proton 
transfer gives a peroxy species 5 that is set 
up to lose water (red), to generate a hydrated 
ferry1 oxene 6. After proton transfer, the valinyl 
nitrogen lone pair of 7 can close onto the 
bound thioaldehyde to give a protonated 
p-lactam intermediate 8. Rotation of the 
valinyl isopropyl group must accompany this 
ring closure to relieve steric compression. 
The proton on the valinyl nitrogen (blue) is 
then removed by the iron hydroxide (red), 
resulting in intermediate 9, whrch loses water 
again to relieve steric compression. The ferry1 
oxene of 10 (red) then undergoes a 
[o2s+n2aI cycloaddition with the valinyl 
tertiary C-H bond (blue) to give a 
metallocyclic intermediate 11. After solvent- 
mediated iron hydroxide protonation, 
reductive elimination from 12 generates the 
enzyme-bound product (IPN, 2). 
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The study of one substrate analogue has been particularly two penams is less exothermic such that the perturba- 
revealing; &(L-&aminoadipoyl)-L-cysteinyl-D-a-amino- tions affect ground-state-and transition-state-binding dif- 
butyrate (ACAB, 13, which lacks one of the methyl ferentially. The results of this heuristic analysis were 
groups of the natural substrate) is converted to three interpreted according to a reaction scheme based on 
products, the P-methyl penam 20, the a-methyl penam three conformational states (see Figure 3). Two-electron 
21 and the cepham 22, by IPNS (see Figure 3) [7,8]. oxidation of ACAB 13 produces a monocyclic ferryl- 
Comparing the ratios of these three products from the oxene intermediate that can exist in three conforma- 
conversion of ACAB 13 by four different IPNS isozymes tional states about the a-aminobutyrate C&C3 bond, the 
enabled several conclusions to be drawn [9]. The invari- ‘methyl-up’ conformer 14, the ‘methyl-left’ conformer 15 
ance of the ratio of combined penam products to the and the ‘methyl-right’ conformer 16. Oxidative insertion 
cepham, (20+21):22, suggested, by applying Hammond’s of the ferryl-oxene moiety into a C-H bond of these con- 
postulate [lo], that the chemical step that discriminates formers produces the metallocyclic intermediates 17, 18 
between the penams and the cepham is highly exother- and 19, from 14, 15 and 16, respectively. The oxidative 
mic. The minor perturbations caused by sequence differ- addition step discriminates between the formation of 
ences between the isozymes do not affect the product penam and cepham products and was suggested by our 
ratio (20+21):22 because ground-state binding differ- analysis to be highly exothermic, in accordance with 
ences are reflected by very similar transition-state differ- chemical expectations. The monocyclic ferry1 oxene 
ences. On the other hand the ratio of p- to a-methyl intermediate must have a significant lifetime, however, 
penams, 2021, was found to be significantly variable because the overall reaction is sensitive to substrate 
implying that the step that discriminates between the deuteration at the valinylla-aminobutyryl-3-position [Z], 
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Figure 3 
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Processing of an ACV analogue by IPNS. (a) The mechanism of 
conversion of 6-(L-a-aminoadipoyl)-L-cysteinyl-o-a-aminobutyrate 
(ACAB 13) by IPNS [7,8). Three conformers at the ferry1 oxene stage 
(14, 15 and 18) undergo cycloaddition to give the metallocyclic 
intermediates 17, 18 and 19 (17 and 18 can interconvert by way of a 
diradical intermediate). Reductive elimination then generates the 
P-methyl-penam (20), a-methyl-penam (21) and cepham (22) 
products. (b) Schematic representation of the chemistry portrayed in 
(a). The chemistry takes place in a hydrophobic pocket created by 
the isopropyl methyl groups of Leu231 and Val272 at the lower left 
(blue) and the sidechains of Leu223 (again the isopropyl methyl 
groups) and Pro283 at the top (purple). The relative ground-state 
positions of these residues are not indicated, as there must be small 
but significant changes throughout the reaction cycle. The general 
disposition of the residues comprising the hydrophobic pocket is 
unlikely to change, however. Accordingly, the general area occupied 
by these residues is shown by the coloured surfaces in this and 
subsequent figures. The iron centre (pink) imposes an additional 
steric constraint on binding. The metallocyclic intermediates leading 
to the two penam products can interconvert through the 
intermediacy of a freely rotating diradical [8). 
suggesting that, although the oxidative addition is highly 
exothermic, there is a high, rate-determining barrier that 
must be overcome. The oxidative addition step is there- 
fore a good candidate for positive catalysis by the 
enzyme. Deuteration of the 3-position of valine in ACV 1 
leads to the formation of small amounts of a shunt 
metabolite, suggesting that the ‘wrong’ chemistry is 
somehow disfavoured at the stage of the monocyclic 
ferry1 oxene intermediate. The metallocycle 19 (possibly 
in equilibrium with a diradical) can then undergo reduc- 
tive elimination to give the cepham 22. Isotopic labelling 
studies clearly indicate the interconversion of the two six- 
membered metallocycles 17 and 18 presumably through a 
freely rotating diradical [8]. The event that discriminates 
between the two penam products is the reductive elimi- 
nation to give the p- and a-methyl penams 20 and 21, 
from 17 and 18 respectively. The comparative analysis 
suggested that the reductive elimination step is less 
exothermic than the oxidative addition step, and the fact 
that stereochemical interconversion through the interme- 
diacy of the diradical is possible [8] also suggests that the 
metallocycles 17 and 18 (and, by inference, 19) must have 
significant lifetimes. 
We have been interested in assessing the ways in which 
IPNS catalyses the complicated chemistry of this reac- 
tion and the way in which such an enzyme might have 
evolved. In particular, we seek to explain why other 
products that might potentially arise from the oxidative 
processing of ACV 1 are not observed (for example, 
cephams deriving from addition of the ferry1 oxene to 
primary C-H bonds of the methyl groups of 1). In this 
paper, we report results with active-site mutants of IPNS 
that shed new light on these issues. 
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alPNS mutants used in this study. (a) Construction of vectors 
encoding the IPNS mutants; pXTN316 was constructed by 
subcloning the Aspergihs niddans pcbC gene [l I] encoding 
alPNS into a chloramphenicol-resistant derivative of pMak2. 
Introduction of a synthetic cassette containing an Aatll site into 
pXTN316/Eagl, Pstl gave pXTN317 (Leu2234le). Introduction of 
smaller synthetic cassettes into pXTN317 cleaved by Aatll and Pst 
then gave pXTN318 (Leu223-1Val) and pXTN319 (Leu223+Ala). 
(b) Product distribution from the conversion of the substrate 
analogue ACAB 13 by the wild-type IPNS and Leu2234e and 
Leu223+Val active-site mutants. 
4 
Results and discussion 
Given the analysis of the conversion of ACAB 13 by IPNS, 
we reasoned that our novel binding model co’uld be tested 
by mutating Leu223 to other residues that would alter the 
steric demands of the ACV-binding pocket; in addition 
the effect of these mutations on the product ratios would 
provide further mechanistic information about IPNS. 
Recombinant Aspeq$hs nidul’ans IPNS (pcbC/aIPNS) was 
selected as the isozyme for our mutagenesis experiments 
because the expression levels, purification and stability are 
better than for the recombinant isozymes from Cephalospo- 
c&n acretnonitcm, Streptomyces lipmanii and Penidium 
chysogenum [l I]. Because we envisaged an extensive series 
of mutagenesis experiments, we decided to construct a 
vector expressing a fusion protein that could be rapidly 
purified using affinity chromatography. Maltose-binding 
protein (MalE) was selected as the fusion partner and a 
vector, pXTN316, suitable for cassette mutagenesis of the 
Leu223 region was constructed (see Figure 4) [3]. Expres- 
sion of the ma&pcbC fusions yielded large amounts of the 
wild-type and mutant fusion proteins that were conve- 
niently purified using gel-filtration chromatography or 
affinity chromatography on amylose eluting with maltose- 
containing buffers. Incubation experiments with the IPNS 
mutants and ACV 1 or ACAB 13 were conducted side-by- 
side under identical conditions. Products were analysed 
using rH nuclear magnetic resonance (NMR) spectroscopy 
(D,O, 500MHz). Experiments in which the wild-type 
fusion protein was compared to unfused IPNS revealed 
that kinetic parameters were unaffected by the presence of 
the maltose-binding protein, other than the effect of 
increased molecular weight. With ACV 1, a progressive 
decrease in specific activity was observed as Leu223 was 
changed to isoleucine, valine or alanine. In all cases, 
however, the only B-lactam product detected was the 
normal product (IPN, Z), and no cephams (for which syn- 
thetic standards were available) were detected. Conver- 
sions of ACAB 13 by the LeuZ23+Ala mutant were very 
low and are not considered further here except to say that 
the trend in favour of the B-methyl penam 20 was contin- 
ued. The results of conversion of ACAB 13 by the other 
IPNS mutants are shown in Figure 4. 
As is evident from Figure 4, decreasing the steric demand 
of the sidechain of residue 223 alters the products, increas- 
ing the amount of P-methyl penam 20 relative to the 
cepham 22. Under the conditions of the experiment, the 
a-methyl penam 21 was only just detectable with the wild- 
type fusion and was not detected in experiments using the 
LeuZZ3+Ile or LeuZ23~Val mutants. In contrast to our 
earlier results using different isozymes [ll], the penam: 
cepham ratio is clearly altered by mutagenic perturbation 
in this case. With wild-type IPNS (pXTN316), the ratio of 
B-methyl penam 20 to cepham 22 was l:l, with the 
Leu223+Ile mutant (pXTN317) the ratio was 32 and 
234 Chemistry & Biology 1998, Vol 5 No 4 
Figure 5 
W 
Penam Cepham Penam Penam Cepham Penam 
Chemistry & Biology 
The effect of active-site mutations on the energetics of processing 
ACAB 13 by alPNS. (a) Energetics of rotation and oxidative addition for 
wild-type IPNS and ACAB 13. Conformational energy barriers (blue) are 
considerably lower than the corresponding barriers for oxidative 
addition (red). (b) Energetics of rotation and oxidative addition for the 
isoleucine and valine IPNS active-site mutants and ACAB 13. 
with the Leu223+Val mutant (pXTN318) the ratio 3:l. 
An explanation for these observations can be provided 
with reference to Figures 5 and 6. 
The previous analysis [9] strongly suggested that the 
oxidative addition reaction is relatively exothermic. As a 
consequence of the Hammond postulate, any minor per- 
turbation that stabilises or destabilises one of the confor- 
mational states 14, 15 or 16 would similarly stabilise or 
destabilise the transition-state leading from that particu- 
lar conformer. Because the three conformers 14,lS and 16 
can rotate with energy barriers lower than those for the 
subsequent oxidative addition, the Curtin-Hammett 
principle [12] prevails. The penam:cepham ratio is there- 
fore governed solely by the relative heights of the energy 
barriers for the respective oxidative additions. The 
heights of these barriers are not changed by minor pertur- 
bations and the ratio of penams 20 and 21 to cepham 22 
remains essentially constant. The active-site mutations 
studied here constitute major perturbations of IPNS, 
however, and result in the upper part of the enzyme’s 
hydrophobic pocket being less sterically demanding. The 
consequent increase in the stability of conformer 14 rela- 
tive to conformers 15 and 16 results in the activation 
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The effect of active-site mutations on the energetis of the a/b-methyl 
penam discriminating step. (a) Energetics for interconversion of (blue) 
and reductive elimination from (red) metallocyclic intermediates 17 and 
16 with wild-type IPNS. (b) Corresponding energetics for the 
isoleucine and valine IPNS active-site mutants. 
barrier to rotation about the a-aminobutyryl-C&C3 bond 
being increased to the extent that it is comparable to the 
activation barrier for oxidative addition. At this point, the 
Curtin-Hammett principle no longer prevails and the 
ratio of penams 20 and 21 to cepham 22 increases. 
The stabilisation of conformer 14 relative to conformers 15 
and 16 could be caused in two ways; either conformer 14 
could be stabilised or conformers 15 and 16 could be 
destabilised. It seems unlikely that mutations that create 
more space in the active site could destabilise conformer 
16, which suffers from steric interactions between the 
methyl group and the ferry1 oxene moiety, so it seems 
likely that the mutations act by stabilising the ‘methyl-up’ 
conformer 14. If, in the wild-type, Leu223 was involved 
in an ideal van der Waals contact with a substrate methyl 
group in the ‘up’ position, then changing Leu223 to a 
sterically less demanding residue would not increase the 
degree of stabilisation - rather, it should decrease it. It is 
thus necessary to conclude that, in the wild-type, the fit 
between Leu223 and a methyl group in the ‘up’ position 
is too tight to be stabilising and is,, in fact, unfavourable. 
The fact that processing of ACAB; by wild-type IPNS 
gives roughly comparable amounts of B-methyl penam 20 
and cepham 22 when Leu223 destabilises the ‘methyl- 
up’ conformer 14 implies that the ‘methyl-right’ con- 
former 16 must be equally unfavoured. Similar arguments 
suggest that the ‘methyl-left’ conformer 15 must be the 
most disfavoured of the three rotamers. The steric pres- 
sure on the methyl group of the ‘methyl-left’ 15 con- 
former appears to be caused by the hydrophobic residues 
Leu231 and Va1272. Experiments to investigate the 
effects of mutating these residues are now in progress. 
Thus occupancy of the three conformational states at the 
monocyclic ferry1 oxene stage during ACAB 13 process- 
ing is dictated by the methyl group occupying the two 
least bad positions. The penam:cepham ratio is deter- 
mined by the effect these conformational preferences 
have on the oxidative addition step. 
The relative amounts of the two penams (20, 21) are 
determined at the later stage of reductive elimination (see 
Figure 6). The reductive elimination is not as exothermic 
as the oxidative addition step so, according to Hammond’s 
postulate, the transition states for reductive elimination 
respond to minor perturbation differently than do the 
metallocycles. The ratio of 20 to 21 using the different 
IPNS isozymes is therefore variable [9]. The preference 
for production of the B-methyl-penam 20 indicates that 
the barrier leading to 20 is lower than the barrier leading 
to 21. Given the nature of the hydrophobic pocket, it is 
likely that the metallocycle 17, P-methyl penam 20 and 
the transition state in between are all lower in energy than 
the corresponding states leading to the a-methyl penam 
21. In the case of the IPNS active-site mutants, stabiliza- 
tion of 17 relative to 18 means that the height of the inter- 
conversion barrier is comparable to the height of the 
reductive elimination barriers. Because of the reduced 
exothermicity of the reductive elimination step, the transi- 
tion state between 17 and 20 will be differentially sta- 
bilised relative to 17 by the mutant enzymes mutations. 
Because the reductive elimination involves the methine 
carbon migrating from the ferry1 centre to the cysteinyl- 
derived sulphur atom, the decreased steric bulk in this 
region should result in the transition state for the shift 
being preferentially stabilised, relative to 17. Therefore 
the B-methyl penam 20 predominates. 
In the case of the the natural substrate, ACV 1, an argu- 
ment can now be put forward to explain the lack of 
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Figure 7 natural substrate 1 (relative to ACAB 13) means that the 
two possible conformations (24 and 25) leading to cepham 
products both suffer from two severely unfavourable 
interactions (24 is unavailable because of pressure from 
the iron centre and from above, 25 is unavailable because 
of pressure from the iron centre and from below left). 
The least disfavoured conformation (23) is therefore the 
only available state. The steric pressure exerted on con- 
former 23 is partly relieved upon oxidative addition to 
give the metallocycle 26; the oxidative addition step is 
therefore catalysed by steric effects. Equilibration of the 
metallocycle 26 with the diradical 27 is assumed possible 
(the carbon-centred radical is tertiary) but isotopic 
labelling results rule out free rotation of this diradical 
[13]; presumably the extra methyl group in 1 relative to 
13 results in the energetic barrier for free rotation of 27 
also being unsurmountable. Reductive elimination from 
26 then generates bound product 2. In the case of the 
mutant enzymes, the two conformational states (24 and 
25) leading to cepham products are still disfavoured and 
product 2 results from oxidative addition to give con- 
former 23. The reduced steric pressure results in this 
being a less efficient reaction than with the wild-type 
enzyme, however. It remains to be seen whether the 
diradical 27 can rotate in the mutant enzymes, which is 
now clearly a possibility. 
In summary, the results and analysis presented here indi- 
cate the extent to which IPNS has evolved to use steric 
control of conformation as a way to mediate catalysis (see 
Figure 8). Further reduction of steric pressure by active- 
site mutagenesis is likely to result in cepham products 
(most likely the B-methyl cepham 31) and increased 
amounts of the shunt metabolite 28 (formed via the inter- 
mediacy of 29 when the ferry1 oxene is allowed to persist). 
It seems likely, therefore, that primitive IPNS enzymes 
produced more than one product (for example, hydroxyla- 
tion products can be derived from a high energy species 
such as 10). Evolutionary selection for the production of 2 
would then have provided the pressure for the use of 
steric control to decelerate processes leading to unuseful 
products and to accelerate the process leading to 2. 
Significance 
The oxidative cyclisation of &(L-cr-aminoadipoyl)- 
L-cysteinyl-D-valine to isopenicillin N by isopenicillin N 
synthase (IPNS) is a key step in the biosynthesis of an 
important class of antibiotics comprising the penicillins 
and cephalosporins. A combination of X-ray crystallog- 
raphy and the use of substrate analogues has gone a 
long way towards explaining the mechanistic basis of 
this chemically remarkable transformation. Because 
the first crystal structure of IPNS 131 did not indicate 
the mode of substrate binding, we generated a model for 
substrate binding [41. We postulated that the natural 
substrate of IPNS interacted with four residues at the 
1 
(a) 
25 
% 
Chemistry & Biolog! 
Schematic representation of the role of steric control of conformation 
in the reaction of (a) ACV 1 with wild-type IPNS and (b) with the 
isoelucine and valine active-site mutants. 
cepham products in the reaction catalysed by wild-type 
IPNS (see Figure 7). The extra methyl group in the 
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Figure 8 
The likely development of steric control of 
conformation as a means of maximising the 
yield of a biologically active product at the 
expense of biologically inactive by-products. 
See text for further details. 
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active site - Leu223 and Pro283 at the ‘top’ of the processing of the substrate analogue b-(L-a-aminoad- 
active site and Leu231 and Va1272 below. This was ipoyl)-L-cysteinyl-D-o-aminobutyrate increased as the 
confirmed by a more recent structure [61. To further cavity was made larger (when IPNS processes its 
investigate the mechanism of IPNS, we increased the natural substrate only one product - a penam - is 
size of the active-site cavity above the substrate by generated). These results are interpreted in terms of the 
mutating Leu223 to isoleucine, valine or alanine. The enzyme exerting steric control of conformation of the 
ratio of p-methyl penam to cepham products from the natural substrate to prevent the formation of otherwise 
238 Chemistry & Biology 1998, Vol 5 No 4 
likely products. This aspect of enzymic catalysis is 
important for those exothermic enzyme-catalysed reac- 
tions in which several products are possible and only 
one is selected for evolutionarily. 
Materials and methods 
General details 
‘H-NMR spectra were recorded on a Bruker AMX500 (500MHz) 
spectrometer equipped with a 3 mm Nalorac microprobe and the 
solvent signal (D,O) was used as an internal reference. High perfor- 
mance liquid chromatography (HPLC) purifications were carried out 
on a Gilson HPLC system equipped with Gilson 305 and 306 pumps, 
a variable wavelength detector, an 806 manomeric module and a 
model 231 Biosample injector. HPLC instrument control, data collec- 
tion and analysis were performed on an IBM PSl model 486DX-33 
computer equipped with Microsoft Windows v.3.3 and Gilson 715 
v.1.2 software, connected via a Gilson 621 interface module. 
Reverse-phase HPLC was carried out using a C,, HypersilTM or a 
MicrosorbTM C,, column. 
Reagents and enzymes 
&(L-a-Aminoadipoyl)-L-cysteinyl-o-valine (ACV) 1 was a generous 
gift of Glaxo (now Glaxo-Wellcome Plc, Stevenage, UK). 
6-(L-Aminoadipoyl)-L-cysteinyl-D-(a-aminobutyrate) (ACAB) 13 was 
prepared according to literature procedures [7] and purified using 
reverse-phase HPLC. 
Restriction endonucleases and appropriate 1 Ox buffer concentrates 
were purchased form Pharmacia and New England Biolabs. Chloram- 
phenicol was purchased from Sigma. IPTG was purchased from Nov- 
abiochem. Molecular weight markers for protein and DNA gels were 
purchased from Gibco-BRL. Sequenase 2.0 for DNA sequencing was 
purchased in kit form from USB. Deoxynucleotide a-s5S-thiotriphos- 
phates were purchased from Amersham International. 
Amylose resin for affinity chromatography purification of maltose 
binding protein fusions was purchased from New England Biolabs. 
Sephadex G-25 PD-10 columns for gel filtration chromatography and 
Sephadex G-25 Nap-5 columns for buffer exchange operations were 
purchased from Phamacia Biotech. 
Bacterial strains and DNA 
XL1 -Blue (recA1, endAl, gyrA96, thil, hsdRl7, supf44, ret/Al , lac, 
(F’proAB, /a&, /acZ3M15, Tnl 0 (tet r)) and NM554 (recA1, araD139, 
3(araABC-leu) 7697, 3/a&74, galls-, gal K-, hsd R, hsd M+, rspL, strA, 
thi, mcrA(-), mcrB (-)) strains of E. co/i were used. Bacteria were 
grown at 27’C in Luria-Bertani medium (LB) or on plates. Chloram- 
phenicol (30 pg ml-l) was used as an antibiotic supplement. 
Oligonucleotides were synthesized with a Beckman Oligo 1000 DNA 
synthesizer on a 30 nM scale. 
Construction of mutants 
pXTN316 was constructed by subcloning the Aspergillus nidulans 
p&C gene [l 11 encoding IPNS into a chloramphenicol-resistant deriv- 
ative of pMal-c2 (pAlL105). Introduction of a synthetic cassette con- 
taining an Aatll site and the Leu223tlle mutation into pXTN316/EagI, 
Pstl gave pXTN317. Introduction of smaller synthetic cassettes into 
pXTN317/Aatll, fstl then gave pXTN318 (223+Val mutation) and 
pXTN319 (223+Ala mutation). 
Expression of wild-type alPNS and mutant alPNS 
f. co/i. strain NM554 was transformed with the appropriate plasmid. 
Transformation mixtures were plated at 27°C onto LB agar containing 
chloramphenicol (30 pg ml-l). Single colonies were used to inoculate 
5 ml of LB containing chloramphenicol (30 pg ml-l) and the cultures 
were grown overnight at 27’C and 250 rpm. The overnight cultures were 
used as 1% inocula into 100 ml of LB media containing chloramphenicol 
(30 pg ml-‘). Cultures were incubated at 27°C. When the OD,,, was 
between 0.4 and 0.6 IPTG was added to the cultures to a final concen- 
tration of 0.5 mM. Cells were harvested by centrifugation at 3500 rpm 
and lysed by sonication. Soluble lysates were analysed by sodium 
dodecyl sulphate-polyactylamide gel electrophoresis (SDS-PAGE). The 
wild-type IPNS vector pXTN313 yielded MBP:IPNS as -45% of the total 
soluble protein, IPNS mutant vector pXTN317 yielded -40% and 
pXTN318 and pXTN319 both yielded -30%. 
Purification of wild-type alPNS and mutant alPNS 
Expression of the ma/E:pcbC fusions yielded large amounts of the 
wild-type and mutant fusion proteins which were conveniently purified 
using gel-filtration chromatography on Sephadex G-25 M PD-10 
column or affinity chromatography using an amylose resin and eluting 
with maltose-containing buffers. Purified protein was quantified using 
the method of Bradford and the specific activities of wild-type and 
mutant alPNS were measured by plate bioassay and HPLC assay on a 
reverse-phase column. 
Incubation of &CL-a-aminoadipoyl)-L-cysteinyl-D-valine 
(ACV) 1 and &(L-a-aminoadipoyi)-L-cysteiny/-D-(&amino- 
butyrate) (ACAB) 13 with wild-type and mutant alPNS 
Protein samples were thawed and buffer exchanged into 50 mM 
NH,HCO, on a Sephadex G-25 Nap-5 column immediately prior to 
use. One milligram of ACV 1 or ACAB 13 was dissolved in 200 ~1 of 
buffer and 200 l.~l each of 100 mM dithiothreitol (DlT), 44 mM ascor- 
bate and 1 mM Fe,SO, (all made up in water) were added. This sub- 
strate and cofactor mix was added to the enzyme preparation in a 
round bottom glass flask and the reaction mixture was incubated for 
30 min at 27’C and 250 rpm in a bench-top orbital shaker. Cold 
acetone -4°C was added to 70% by volume, and the protein was pre- 
cipitated for 5 min at room temperature. Precipitated protein was 
removed by centrifugation at 13500 rpm for 5 min and the acetone 
then removed on a vacuum centrifuge. The aqueous remainder was 
frozen and lyophilized. The lyophilisate was dissolved in 200 pl of D,O 
passed through a sterile 0.22 vrn filter and the ‘H-NMR spectrum was 
examined for the presence of characteristic p-lactam resonances in the 
region of 64.8-6.0 ppm. All incubations showed a total conversion of 
the substrate except for the pXTN319 mutant with ACAB 13. The 
p-lactam resonances observed were assigned on the basis of ‘H-NMR 
spectra of previously purified metabolites, as detailed below. 
Incubation of ACV 1: (2S,5R,6R)-6-[(5S)-5-Amino-5-carboxypentan- 
amidol-3,3-dimethyl-7-0x0-1 -aza-4-thiabicyclo[3.2.0]heptane-2-carboxylic 
acid (IPN) 2 6H (500 MHz, D,O), 5.35 and 5.45 (2H, ABq, J 4 Hz, 5-H 
and 6-H). 
Incubation of ACAB 73: (2S,3S, 5R,6R)-6-[(5S)-5-Amino-5-carboxypen- 
tanamidol-3-methyl-7-0x0-1 -aza-4-thiabicyclo 13.2.01 heptane-2-carboxylic 
acid (P-methyl penam 20) 6, (500 MHz, D,O), 5.31 and 5.37 (2H ABq, 
J 4 Hz, 5-H, 6-H). (2S,3R, 5R,6R)-6-[(5S)-5-Amino-5-carboxypen- 
tanamidol-3-methyl-7-0x0-1 -aza-4-thiabicyclo [3.2.0] heptane-2carboxylic 
acid (a-methyl penam 21) 6, (500 MHz, D,O), 5.36 and 5.45 (2H ABq, I 
4Hz, 5-H, 6-H ). (2S,6R,7R)-7-[(5S)-5-Amino-5-carboxypentanamidol-8- 
0x0-1 -aza-5-thiabicyclo[4.2.0]octane-2-carboxylic acid (Cepham 22) 6, 
(500 MHz, D,O), 5.15 and 5.28 (2H, ABq, J 4Hz, 6-H and 7-H). 
Analysis of substrate conversions 
Incubation of wild-type alPNS and the several mutant alPNS with ACV 1 
showed in each case a total conversion to a single product, IPN 2. The 
specific activity decreased when Leu223 was changed in to isoleucine 
(pXTN317), valine (pXTN318) or alanine (pXTN319). Incubation of wild- 
type alPNS and mutant alPNS with ACAB 13 showed a total conversion 
into two main products, P-methyl penam 20 and cepham 22, except for 
the Leu223+Ala mutant (pXTN319) which gave very low conversions 
and is not considered here. The product distribution was affected by the 
catalyst. With the wild-type IPNS (pXTN316) the ratio of p-methyl penam 
20 to cepham 22 was 1 :l , with the Leu223+lle mutant (pXTN317) the 
ratio was 3:2 and with the Leu223+Val mutant (pXTN318) 3:l. 
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